Trials
Search / Trial NCT05639283

Primary Obstructive Megaureter Management in Eastern Interregional Area

Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Nov 28, 2022

Apply for Trial

Trial Information

Current as of January 13, 2025

Completed

Keywords

Congenital Obstructive Megaureter Urinary Malformation Ureterovesical Junction Hydronephrosis Renal Dysplasia

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Minor patient (from 1 to 17 years old)
  • • Patient treated between January 2010 and December 2017 in one of the participating centers for an obstructive congenital mega-ureter
  • • Subject (and/or his parental authority) not having expressed, after information, his opposition to the reuse of his data for the purposes of this research
  • Exclusion Criteria:
  • • Subject (and/or his parental authority) having expressed, after information, his opposition to the reuse of his data for the purposes of this research

About University Hospital, Strasbourg, France

The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.

Locations

Strasbourg, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials